Filing Details

Accession Number:
0001144204-15-056995
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-29 11:47:26
Reporting Period:
2015-09-28
Filing Date:
2015-09-29
Accepted Time:
2015-09-29 11:47:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP Pharmaceutical Preparations (2834) 261434750
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1563615 Leland Gershell C/O Tonix Pharmaceuticals Holding Corp
509 Madison Ave., Ste 306
New York NY 10022
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2015-09-28 400 $5.83 19,260 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.825. The range of purchase prices on the transaction date was $5.82 to $5.83 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.